{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T13:08:52Z","timestamp":1781788132090,"version":"3.54.5"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministry of Health of the Czech Republic","doi-asserted-by":"publisher","award":["IGA MZ CR NT-12166-5\/2011"],"award-info":[{"award-number":["IGA MZ CR NT-12166-5\/2011"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministry of Health of the Czech Republic","doi-asserted-by":"publisher","award":["MZ CR AZV16-31932A"],"award-info":[{"award-number":["MZ CR AZV16-31932A"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001824","name":"Grant Agency of the Czech Republic","doi-asserted-by":"publisher","award":["GACR 14-36804G"],"award-info":[{"award-number":["GACR 14-36804G"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.metabol.2018.01.004","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T07:12:53Z","timestamp":1517555573000},"page":"135-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Aberrant apolipoprotein C-III glycosylation in glycogen storage disease type III and IX"],"prefix":"10.1016","volume":"82","author":[{"given":"Nina","family":"Ondruskova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Honzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Kolarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Pakanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Mucha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Zeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Hansikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2018.01.004_bb0005","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1373\/clinchem.2006.073940","article-title":"Transferrin and apolipoprotein C-III isofocusing are complementary in the diagnosis of N- and O-glycan biosynthesis defects","volume":"53","author":"Wopereis","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.metabol.2018.01.004_bb0010","article-title":"Congenital disorders of glycosylation (CDG): quo vadis?","author":"P\u00e9anne","year":"2017","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.metabol.2018.01.004_bb0015","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/ng.2007.45","article-title":"Group AD-tS: impaired glycosylation and cutis laxa caused by mutations in the vesicular H+-ATPase subunit ATP6V0A2","volume":"40","author":"Kornak","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.metabol.2018.01.004_bb0020","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s10545-005-0015-z","article-title":"Clinical and biochemical presentation of siblings with COG-7 deficiency, a lethal multiple O- and N-glycosylation disorder","volume":"28","author":"Spaapen","year":"2005","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.metabol.2018.01.004_bb0025","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1073\/pnas.0507685103","article-title":"Conserved oligomeric Golgi complex subunit 1 deficiency reveals a previously uncharacterized congenital disorder of glycosylation type II","volume":"103","author":"Foulquier","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2018.01.004_bb0030","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/hmg\/ddl476","article-title":"A new inborn error of glycosylation due to a Cog8 deficiency reveals a critical role for the Cog1-Cog8 interaction in COG complex formation","volume":"16","author":"Foulquier","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.metabol.2018.01.004_bb0035","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1093\/hmg\/ddp389","article-title":"Deficiency in COG5 causes a moderate form of congenital disorders of glycosylation","volume":"18","author":"Paesold-Burda","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.metabol.2018.01.004_bb0040","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1093\/hmg\/ddq278","article-title":"Fatal outcome due to deficiency of subunit 6 of the conserved oligomeric Golgi complex leading to a new type of congenital disorders of glycosylation","volume":"19","author":"L\u00fcbbehusen","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.metabol.2018.01.004_bb0045","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/cge.12417","article-title":"Mutations in COG2 encoding a subunit of the conserved oligomeric golgi complex cause a congenital disorder of glycosylation","volume":"87","author":"Kodera","year":"2015","journal-title":"Clin Genet"},{"key":"10.1016\/j.metabol.2018.01.004_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119983","article-title":"N-glycomic changes in serum proteins in type 2 diabetes mellitus correlate with complications and with metabolic syndrome parameters","volume":"10","author":"Testa","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2018.01.004_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104833","article-title":"Reduced apolipoprotein glycosylation in patients with the metabolic syndrome","volume":"9","author":"Savinova","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2018.01.004_bb0060","first-page":"273","article-title":"The effect of malnutrition on protein glycosylation in children","volume":"24","author":"Bilen","year":"2014","journal-title":"Iran J Pediatr"},{"key":"10.1016\/j.metabol.2018.01.004_bb0065","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00296-013-2921-y","article-title":"Sialic acid level reflects the disturbances of glycosylation and acute-phase reaction in rheumatic diseases","volume":"34","author":"Chrostek","year":"2014","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.metabol.2018.01.004_bb0070","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1093\/ndt\/10.7.1121","article-title":"Abnormal glycosylation of IgA: is it related to the pathogenesis of IgA nephropathy?","volume":"10","author":"Allen","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.metabol.2018.01.004_bb0075","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1365-2788.2010.01323.x","article-title":"Analysis of N- and O-linked protein glycosylation in children with Prader-Willi syndrome","volume":"54","author":"Munce","year":"2010","journal-title":"J Intellect Disabil Res"},{"key":"10.1016\/j.metabol.2018.01.004_bb0080","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1021\/pr800751x","article-title":"O-glycoside biomarker of apolipoprotein C3: responsiveness to obesity, bariatric surgery, and therapy with metformin, to chronic or severe liver disease and to mortality in severe sepsis and graft vs host disease","volume":"8","author":"Harvey","year":"2009","journal-title":"J Proteome Res"},{"key":"10.1016\/j.metabol.2018.01.004_bb0085","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1056\/NEJMc0901158","article-title":"Muscle glycogenosis due to phosphoglucomutase 1 deficiency","volume":"361","author":"Stojkovic","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2018.01.004_bb0090","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1093\/hmg\/dds123","article-title":"Gene identification in the congenital disorders of glycosylation type I by whole-exome sequencing","volume":"21","author":"Timal","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.metabol.2018.01.004_bb0095","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s10545-014-9785-5","article-title":"Glycogen pathways in disease: new developments in a classical field of medical genetics","volume":"38","author":"Kilimann","year":"2015","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.metabol.2018.01.004_bb0100","series-title":"Inborn metabolic diseases: diagnosis and treatment","first-page":"121","author":"Saudubray","year":"2016"},{"key":"10.1016\/j.metabol.2018.01.004_bb0105","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ymgme.2007.06.007","article-title":"Glycogen storage disease type IX: high variability in clinical phenotype","volume":"92","author":"Beauchamp","year":"2007","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.metabol.2018.01.004_bb0110","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ymgme.2014.09.005","article-title":"The natural history of glycogen storage disease types VI and IX: long-term outcome from the largest metabolic center in Canada","volume":"113","author":"Roscher","year":"2014","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.metabol.2018.01.004_bb0115","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ymgme.2011.05.010","article-title":"Liver glycogen storage diseases due to phosphorylase system deficiencies: diagnosis thanks to non invasive blood enzymatic and molecular studies","volume":"104","author":"Davit-Spraul","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.metabol.2018.01.004_bb0120","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S1096-7192(03)00068-4","article-title":"A novel mutation (G233D) in the glycogen phosphorylase gene in a patient with hepatic glycogen storage disease and residual enzyme activity","volume":"79","author":"Tang","year":"2003","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.metabol.2018.01.004_bb0125","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1086\/301790","article-title":"Mutations in the liver glycogen phosphorylase gene (PYGL) underlying glycogenosis type VI","volume":"62","author":"Burwinkel","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.metabol.2018.01.004_bb0130","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ymgme.2014.06.002","article-title":"Galactose supplementation in phosphoglucomutase-1 deficiency; review and outlook for a novel treatable CDG","volume":"112","author":"Morava","year":"2014","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.metabol.2018.01.004_bb0135","first-page":"S38","article-title":"Oral galactose supplementation in PGM1-CDG: as sweet as it sounds?","volume":"38","author":"Gadomski","year":"2015","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.metabol.2018.01.004_bb0140","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJMoa1206605","article-title":"Multiple phenotypes in phosphoglucomutase 1 deficiency","volume":"370","author":"Tegtmeyer","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2018.01.004_bb0145","doi-asserted-by":"crossref","first-page":"73","DOI":"10.14712\/23362936.2015.48","article-title":"Isoelectric focusing of serum apolipoprotein C-III as a sensitive screening method for the detection of O-glycosylation disturbances","volume":"116","author":"Ondru\u0161kov\u00e1","year":"2015","journal-title":"Prague Med Rep"},{"key":"10.1016\/j.metabol.2018.01.004_bb0150","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/glycob\/cwj017","article-title":"Patients with unsolved congenital disorders of glycosylation type II can be subdivided in six distinct biochemical groups","volume":"15","author":"Wopereis","year":"2005","journal-title":"Glycobiology"},{"key":"10.1016\/j.metabol.2018.01.004_bb0155","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1093\/glycob\/cws086","article-title":"Mass spectrometry of apolipoprotein C-III, a simple analytical method for mucin-type O-glycosylation and its application to an autosomal recessive cutis laxa type-2 (ARCL2) patient","volume":"22","author":"Wada","year":"2012","journal-title":"Glycobiology"},{"key":"10.1016\/j.metabol.2018.01.004_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144138","article-title":"The association of human apolipoprotein C-III sialylation proteoforms with plasma triglycerides","volume":"10","author":"Yassine","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2018.01.004_bb0165","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/glycob\/cwr023","article-title":"G6PC3 mutations are associated with a major defect of glycosylation: a novel mechanism for neutrophil dysfunction","volume":"21","author":"Hayee","year":"2011","journal-title":"Glycobiology"},{"key":"10.1016\/j.metabol.2018.01.004_bb0170","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1074\/jbc.M114.628628","article-title":"Pompe disease results in a Golgi-based glycosylation deficit in human induced pluripotent stem cell-derived cardiomyocytes","volume":"290","author":"Raval","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2018.01.004_bb0175","first-page":"2079","article-title":"Site-specific protein O-glycosylation modulates proprotein processing - deciphering specific functions of the large polypeptide GalNAc-transferase gene family","volume":"2012","author":"Schjoldager","year":"1820","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.metabol.2018.01.004_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070159","article-title":"GALNT2 expression is reduced in patients with type 2 diabetes: possible role of hyperglycemia","volume":"8","author":"Marucci","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2018.01.004_bb0185","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/00004836-198610000-00025","article-title":"Serum cholinesterase in patients with fatty liver","volume":"8","author":"Nomura","year":"1986","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.metabol.2018.01.004_bb0190","doi-asserted-by":"crossref","first-page":"205697","DOI":"10.1155\/2014\/205697","article-title":"Low density lipoprotein-containing circulating immune complexes: role in atherosclerosis and diagnostic value","volume":"2014","author":"Sobenin","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.metabol.2018.01.004_bb0195","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1161\/01.CIR.102.16.1886","article-title":"VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the cholesterol and recurrent events (CARE) trial","volume":"102","author":"Sacks","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2018.01.004_bb0200","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.metabol.2017.03.016","article-title":"Association of apolipoprotein-CIII (apoC-III), endothelium-dependent vasodilation and peripheral neuropathy in a multi-ethnic population with type 2 diabetes","volume":"72","author":"Pek","year":"2017","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2018.01.004_bb0205","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/jcb.24355","article-title":"Identification of lysosomal sialidase NEU1 and plasma membrane sialidase NEU3 in human erythrocytes","volume":"114","author":"D'Avila","year":"2013","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.metabol.2018.01.004_bb0210","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0021-9150(01)00498-1","article-title":"Human plasma trans-sialidase causes atherogenic modification of low density lipoprotein","volume":"159","author":"Tertov","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2018.01.004_bb0215","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ymgme.2015.07.003","article-title":"Key features and clinical variability of COG6-CDG","volume":"116","author":"Rymen","year":"2015","journal-title":"Mol Genet Metab"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049518300106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049518300106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:16:11Z","timestamp":1758428171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049518300106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":43,"alternative-id":["S0026049518300106"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2018.01.004","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aberrant apolipoprotein C-III glycosylation in glycogen storage disease type III and IX","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2018.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}